Background and Purpose: Microvascular barrier breakdown is a hallmark of sepsis
Sepsis is a leading cause of death with infection worldwide (Riedemann, Guo, & Ward, 2003) . It is a life-threatening organ dysfunction caused by a dysregulated host response to infection (Singer et al., 2016; Vincent, Opal, Marshall, & Tracey, 2013) . Septic organ dysfunction is due mainly to an overwhelming systemic inflammatory process, characterized by the activation of inflammatory cells as well as the enhanced production and release of various cytokines (Gill, Taneja, Rohan, Wang, & Mehta, 2014) . Endothelial dysfunction is one of key processes involved in the pathogenesis of sepsis, and it is reported to be associated with patient mortality in the clinic (Backer, Creteur, Preiser, Dubois, & Vincent, 2002; Trzeciak et al., 2007) . It is generally agreed that endothelial dysfunction promotes the adhesion of neutrophils to vascular endothelial cells, coagulation abnormalities, microvascular leakage, and hypoperfusion leading to sepsis-induced multiorgan failure (Aird, 2003) . Thus, the recovery and maintenance of the body's endothelial barrier function must be critical to survival in cases of sepsis. These processes are likely to provide novel targets for the treatment of sepsis.
The endothelial barrier is maintained mostly by the balance between its intrinsic contractility and intercellular adhesive interactions (Hoelzle, Svitkina, & Blanchoin, 2011; Huveneers et al., 2012 ).
The intrinsic contractility-which is produced by cytoskeleton rearrangement, the cortical actin dissolution, and stress fibre formation-can result in endothelial retraction and gap formation (Dejana, Corada, & Lampugnani, 1995; Jean et al., 2014; Nwariaku et al., 2003) . The actin cytoskeleton of endothelial cells is tethered to adherent focal adhesions, which mediate cell-matrix interactions (Burridge, Fath, Kelly, Nuckolls, & Turner, 1988; Wu, 2005) . Cell-cell contacts are mediated by adherent junctions among endothelial cells, and these contacts are composed mainly of VEcadherin. VE-cadherin is an endothelium-specific transmembrane adhesion molecule that regulates the cytoskeleton reorganization via an interaction with actin filaments through catenin binding, which also plays a critical role in modulating endothelial permeability (Gumbiner, 1996; Luscinskas & Shaw, 2001; Rodrigues & Granger, 2015) .
Hyperpermeability is a hallmark of different inflammatory diseases such as acute respiratory distress syndrome and sepsis, and aberrant actin dynamics during sepsis leads to intercellular junction destabilization, vascular hyperpermeability, and immune cell recruitment. Therefore, the actomyosin contractility machinery has become the focus of many studies investigating sepsis (Schnoor et al., 2017) . In this process, RhoA triggers the formation of stress fibres through the phosphorylation of myosin light chain (MLC) by Rho-associated kinase (ROCK; García-Ponce et al., 2016) . Phosphorylated MLC (p-MLC) enables the myosin molecule to change conformation, interact with actin, and slide along its filaments, leading to increased contractility. Members of the MAPK family also interact with the cytoskeleton, and in particular, activated ERK1/2 or p38 was shown to mediate changes in actin dynamics, leading to stress fibre formation, redistribution of VE-cadherin junctions, and permeability changes in endothelial cells (Guay et al., 1997; Nwariaku et al., 2002) .
Activation of the vascular endothelium in septic conditions results in the production of various pro-inflammatory molecules including leukocyte adhesion molecules as well as soluble cytokines and chemokines (Pober & Cotran, 1990) . The activation of NF-κB in endothelial cells is required for the release of pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α (Baeuerle & Baltimore, 1996) . Therefore, the inhibition of NF-κB activation will control the overproduction of cytokines in sepsis conditions, which further protects the barrier function in the pathogenesis of sepsis.
Histidine-rich glycoprotein (HRG) is a 75-kDa plasma protein.
Human HRG is synthesized in the liver and is present in the blood at a concentration range of 60-100 μg·ml −1 (Koide, Foster, Yoshitake, & Davie, 1986) . The primary structure of human HRG is predicted to be a 507-amino acid multidomain polypeptide consisting of two cystatin-like regions at the N-terminus, a histidine-rich region flanked by proline-rich regions, and a C-terminal domain. HRG is an adaptor protein that interacts with many ligands, including Zn
2+
, haem, tropomyosin, heparin, heparan sulphate, plasminogen, and complement (Ronca & Raggi, 2015) .
It has been shown that HRG can regulate many biological processes, such as angiogenesis, coagulation, fibrinolysis, and the phagocytosis of apoptotic cells (Poon, Patel, Davis, Parish, & Hulett, 2011) . Shannon et al. (2010) demonstrated that HRG decreased the mortality of a septic mouse model with Streptococcus pyogenes-induced abscesses by the killing and trapping of bacteria in the abscess sites. Wake et al. (2016) demonstrated that HRG prevents septic lethality through the regulation of neutrophils and the inhibition of the strong attachment of neutrophils to vascular endothelial cells. In recent clinical studies, HRG was further proposed as a new biomarker to predict the outcome of a sepsis patient (Kuroda et al., 2018; . Based on these findings, our present research demonstrates for the first time the protective effects of HRG on the endothelium, especially the barrier dysfunction of endothelium in systemic septic conditions, and the possible mechanism. This will provide new evidence for the use of HRG as a supplementary therapy for the treatment of sepsis.
What is already known
• HRG has an anti-septic effect in mice through the maintenance of neutrophil quiescence.
What this study adds
• HRG produced significant protective effects on vascular endothelial cells in vitro and in vivo.
What is the clinical significance
• The rapid decrease in plasma HRG in sepsis contributes to the dysregulation of vascular endothelial cells. 2.2 | Purification of HRG from human plasma HRG was purified from human plasma by our lab as described previously (Mori, Takahashi, Yamaoka, Okamoto, & Nishibori, 2003 together. The mixed capture beads were co-incubated with 50 μl of supernatant and detection reagent for 2 hr. The beads were then washed carefully and resuspended. Samples were analysed using a FACSCanto II system (BD Biosciences). The data were analysed with FCAP Array software.
| RNA isolation and real-time PCR
Cells were harvested, and mRNA was extracted using an RNeasy mini kit (Qiagen). cDNA was synthesized with a Takara RNA PCR kit Version 3.0 (Takara Bio, Nagahama, Japan) according to the manufacturer's instructions. Real-time PCR was performed with a Light Cycler (Roche, Switzerland) according to the manufacturer's instructions. The primers shown in Table S1 were used to amplify specific cDNA fragments. β-actin expression was used to normalize cDNA levels.
The PCR products were analysed by a melting curve to ascertain the specificity of amplification, and the relative fold gene expression of samples was calculated with the Δ-Δ Ct method. 
| Animals
Adult male C57BL/6N mice (22 ± 3 g, 8 weeks, RRID:MGI_5658420)
were purchased from SLC (Hamamatsu, Japan) and then housed in the Okayama University institutional animal units (12-hr light cycle).
The mice were maintained on a standard rodent diet with free access to water. Up to four mice were kept per plastic cage with aspen wood 
| Randomization and blinding
Animals were randomized for treatment. Data collection and evaluation of all experiments were performed blindly of the group identity.
| Sepsis model
Two types of septic animal models were used in the present study:
an LPS-induced endotoxaemia model and a caecal ligation puncture (CLP) model. The LPS-induced septic model was established with an i.v. injection of LPS (10 mg·kg −1 ) and was used for experiments 12 hr thereafter (London et al., 2010; Xu, Wu, Hack, Bao, & Cunningham, 2015) . The CLP septic animal models were established as described in our previous study (Wake et al., 2016) . Briefly, the mice were anaesthetized with 3% isoflurane in 48.5% N 2 O and 48.5% O 2 , and a ligature was set below the ileocaecal valve. The caecum was gently exteriorized from the peritoneal cavity and punctured twice with an 18-gauge needle and was then returned back to the abdomen. The mice were killed 24 hr later with pentobarbital sodium (50 mg·kg −1 , i.p.).
| Vascular permeability in septic mice
We assessed the vascular permeability of different organs in 
| Rho GTPase pull-down assay
RhoA regulates molecular events by cycling between an inactive GDPbound form and an active GTP-bound form. In this study, RhoA 
| Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMA-COLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017a (Alexander et al., , 2017b Figure S2 ). These protective effects are also true for the HMVECs ( Figure S7 ). Scanning electron microscopy observations also confirmed the formation of intercellular gaps, thickness of the cell membrane, and microparticlelike structure on the cell surface induced by LPS; this was also inhibited by HRG (Figure 2c ). In parallel, the Western blotting results of VE-cadherin also showed that HRG prevented the decrease in the expression of VE-cadherin induced by LPS or TNF-α (Figure 2d,e) .
The phosphorylation and dephosphorylation of intercellular tyrosine residues in the VE-cadherin complex are responsible for the modulation of VE-cadherin function (Weidert, Pohler, Gomez, & Dong, 2014) . Wessel et al. (2014) showed that Tyr 685 and Tyr 731 of VE-cadherin distinctly and selectively regulate the induction of vascular permeability or leukocyte extravasation. In this study, we investigated the effects of HRG on the Y-685 phosphorylation in VE-cadherin. The results showed that HRG effectively inhibited the LPS/TNF-α-stimulated phosphorylation of VE-cadherin at Tyr 685 site (Figure 2d,e) .
Moreover, HRG prevented the LPS/TNF-α-induced loss of other junction molecules like occludin and ZO-1, which were involved in the endothelium permeability control ( Figure S3 ).
| LPS/TNF-α-induced degradation of focal adhesion kinase and cell detachment were reduced by HRG
Focal adhesion kinase (FAK) is associated with actin stress fibres, which serve as holding points for cytoskeletal tension. FAK is responsible for the regulation of cell contractility and cell-matrix adhesion.
LPS was reported to induce the stress fibre formation, associated with phosphorylation and degradation of FAK. The results in Figure 3a showed that LPS and TNF-α induced slight FAK degradation and strongly stimulated phosphorylation of FAK, which were inhibited by the treatment with HRG. These results proved that HRG not only prevented the loss of FAK but also effectively regulated the FAK phosphorylation stimulated by LPS/TNF-α. To further confirm the regulation effects of HRG on cell-matrix adhesion, the cell detachment assay was performed. Results showed that LPS/TNF-α stimulation led to a large number of cells detaching from the plain plates (Figure 3b(A,C) ) and laminin-coated plates (Figure 3b(B,D) ), whereas HRG effectively prevented the cell detachment under both conditions. The results also statistically analysed the measurement of OD of crystal violent remaining on the plates at 595 nm (Figure 3c ). 
| HRG suppresses the cytokine secretion and mRNA expression of inflammation-related molecules in endothelial cells
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Moreover, our previous study (Wake et al., 2016) already proved that the systemic injection of HRG significantly reduced the cytokine levels in the septic mice compared with control HSA-injected group.
In the present study, the effects of HRG on the serum cytokine levels in LPS-injected mice were also determined with cytometric bead array.
HRG significantly reduced the IL-6, IL-10, and TNF-α levels in serum of LPS-injected mice compared with control HSA-injected group ( Figure S4 ).
As presented in Figure 4b , LPS enhanced the expression of all three receptors (TLR2, TLR4, and RAGE) on endothelial cells. Figure S8 ).
| Protective role of HRG on the permeability of vascular endothelium in vitro and in vivo
In the FITC-dextran transwell assay as depicted in Figure 6a , LPS/TNF-α induced significant leakage of 70-kDa FITC-dextran from the endothelial monolayer compared with the control group, and pretreatment with HRG produced a significant inhibition of dextran leakage during the 12-hr stimulation compared with the HSA treatment group. This effect was also true for LPS-induced 150-or 250-kDa FITC-dextran leakage (Figure 6b,c) . Moreover, HRG also showed the inhibitory effects on the LPS/TNF-α-induced hyperpermeability in HMVEC monolayer in vitro ( Figure S5 ).
To examine whether HRG reduces hyperpermeability under cytokine storm conditions in vivo, we used a bacterial endotoxin model of inflammation. LPS administration triggered a large increase in capillary permeability at 12 hr after the injection. Using EBA as a tracer, we observed that HRG significantly reduced the EBA leakage from capillaries in the lung, liver and kidney of LPS-injected mice (Figure 6d ).
To test the physiological relevance of our findings and to determine whether the effect of HRG is limited to the administration of LPS, we used a model of polymicrobial sepsis known as CLP. HRG also significantly reduced vascular permeability in the lung, liver, and kidney after 24 hr in the sepsis-induced barrier dysfunction model (Figure 6e ).
3.7 | HRG prevented the activation of MAPK and Rho signal pathway induced by LPS ROCK and MAPK cascades, which include p38 and ERK1/2, play critical roles in the regulation of VE-cadherin redistribution and cytoskeletal polymerization in endothelial permeability control (Yuan, 2002) .
The results show that LPS stimulation induced p38 and ERK1/2 phosphorylation in a time-dependent manner, as the activation of p38 and ERK1/2 was biphasic with an initial increase (peaking at 1 hr) followed by a slight drop in the phosphorylation levels (Figure 7a,b) . HRG effectively inhibited the phosphorylation of p38 and ERK1/2 induced by LPS (Figure 7c ). The inhibitory effect of HRG on the LPS-induced activation of Rho A (GTP bound) was shown in Figure 7d . The quantification of Western blotting results is illustrated in Figure 7e . Statistical analysis was performed by one-way ANOVA with Bonferroni's post hoc test, **P < .05 versus sham, ## P < .05, and ++ P < .05 versus PBS and HSA respectively BJP VE-cadherin is the major transmembrane intercellular adherens junction that links to the actin cytoskeleton through α-catenin and β-catenin to provide both mechanical stability and the transduction of extracellular signals into the cell, and it thus represents a crucial determinant of endothelial barrier integrity (Dejana & Orsenigo, 2013) . Soluble VE-cadherin appears to play a role in sepsis and has the potential to be a clinical marker for the early detection of the loss of microvascular barrier functions in sepsis (Flemming et al., 2015) . The inhibitory effects of HRG on the IL-8 secretion and expression also supported the previous finding that HRG can strongly suppress the adhesion of neutrophils to lung vasculatures in septic mice (Wake et al., 2016) . Moreover, the suppressive effects of HRG on hypercytokinaemia in septic mice were also observed in the LPSinjected mice ( Figure S4 ). These findings support the hypothesis that HRG may exert anti-septic effects through the regulation of cytokine production and barrier dysfunction in vascular endothelial cells, in addition to a strong regulator role for neutrophils (Wake et al., 2016) .
LPS activates the release of these cytokines by a transcriptional mechanism involving the activation of NF-κB (Cohen, 2002) ; Kuroda et al., 2018; Nishibori et al., 2018) . HRG showed a high sensitivity and specificity for diagnosing sepsis. Moreover, plasma HRG levels were a good prognostic indicator, and the determination of plasma HRG alone could still predict mortality (Kuroda et al., 2018; Nishibori et al., 2018) . Our present research proved that HRG has a potent protective effect on the vascular endothelium barrier under septic conditions, which indicates that HRG is suitable as a supplementary treatment for sepsis. However, the specific mechanism through which HRG mediates this effect on the endothelium needs to be further investigated.
| CONCLUSION
The present study provides strong evidences that HRG efficiently protects vascular endothelial cells under inflammatory conditions. The effects may contribute to the anti-septic effects of HRG administered systemically. Thus, the present study not only clarifies the effects of HRG on vascular endothelial cells but also facilitates our understanding of the pathophysiology of sepsis. As a whole, supplementary therapy with HRG should be encouraged for the treatment of sepsis.
